Persistence with weekly alendronate therapy among postmenopausal women
- 12 April 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Osteoporosis International
- Vol. 17 (6), 922-928
- https://doi.org/10.1007/s00198-006-0085-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosisCurrent Medical Research and Opinion, 2005
- Pioglitazone initiation and subsequent hospitalization for congestive heart failureDiabetic Medicine, 2005
- Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal OsteoporosisJournal of Bone and Mineral Research, 2004
- Compliance with drug therapies for the treatment and prevention of osteoporosisMaturitas, 2004
- The impact of compliance with osteoporosis therapy on fracture rates in actual practiceOsteoporosis International, 2004
- Compliance with pharmacologic therapy for osteoporosisOsteoporosis International, 2003
- Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO databaseOsteoporosis International, 2003
- Early discontinuation of treatment for osteoporosisThe American Journal of Medicine, 2003
- Initiation of Osteoporosis Treatment after Bone Mineral Density TestingOsteoporosis International, 2001
- Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology.American Journal of Public Health, 1992